JP2025515030A5 - - Google Patents

Info

Publication number
JP2025515030A5
JP2025515030A5 JP2024564665A JP2024564665A JP2025515030A5 JP 2025515030 A5 JP2025515030 A5 JP 2025515030A5 JP 2024564665 A JP2024564665 A JP 2024564665A JP 2024564665 A JP2024564665 A JP 2024564665A JP 2025515030 A5 JP2025515030 A5 JP 2025515030A5
Authority
JP
Japan
Prior art keywords
sequence
nucleic acid
nuclease
target sequence
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564665A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515030A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/061582 external-priority patent/WO2023213831A1/en
Publication of JP2025515030A publication Critical patent/JP2025515030A/ja
Publication of JP2025515030A5 publication Critical patent/JP2025515030A5/ja
Pending legal-status Critical Current

Links

JP2024564665A 2022-05-02 2023-05-02 遺伝子編集用の相同性非依存性標的組込み Pending JP2025515030A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22171218.5 2022-05-02
EP22171218 2022-05-02
PCT/EP2023/061582 WO2023213831A1 (en) 2022-05-02 2023-05-02 Homology independent targeted integration for gene editing

Publications (2)

Publication Number Publication Date
JP2025515030A JP2025515030A (ja) 2025-05-13
JP2025515030A5 true JP2025515030A5 (https=) 2026-03-19

Family

ID=82218344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564665A Pending JP2025515030A (ja) 2022-05-02 2023-05-02 遺伝子編集用の相同性非依存性標的組込み

Country Status (8)

Country Link
US (1) US20250288694A1 (https=)
EP (1) EP4518907A1 (https=)
JP (1) JP2025515030A (https=)
CN (1) CN119136844A (https=)
AU (1) AU2023264251A1 (https=)
CA (1) CA3250913A1 (https=)
IL (1) IL316555A (https=)
WO (1) WO2023213831A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025229995A1 (ja) * 2024-04-30 2025-11-06 学校法人自治医科大学 核酸導入用ベクター、核酸導入方法、ポリヌクレオチド、及びベクター

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US113A (en) 1837-01-31 Improvement in the mode of making or preparing door-plates
US6933A (en) 1849-12-11 Brick-press
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
ES2341926T3 (es) 1998-03-02 2010-06-29 Massachusetts Institute Of Technology Poliproteinas con dedos de cinc que tienen enlazadores mejorados.
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US20030104526A1 (en) 1999-03-24 2003-06-05 Qiang Liu Position dependent recognition of GNN nucleotide triplets by zinc fingers
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
WO2003059396A1 (en) 2002-01-11 2003-07-24 Sergei Zolotukhin Adiponectin gene therapy
WO2003080809A2 (en) 2002-03-21 2003-10-02 Sangamo Biosciences, Inc. Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
WO2006036465A2 (en) 2004-09-03 2006-04-06 University Of Florida Compositions and methods for treating cystic fibrosis
AU2008305590A1 (en) 2007-09-27 2009-04-02 Sangamo Therapeutics, Inc. Genomic editing in zebrafish using zinc finger nucleases
WO2011072246A2 (en) 2009-12-10 2011-06-16 Regents Of The University Of Minnesota Tal effector-mediated dna modification
AU2013266968B2 (en) 2012-05-25 2017-06-29 Emmanuelle CHARPENTIER Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
EP3196301B1 (en) * 2012-07-11 2018-10-17 Sangamo Therapeutics, Inc. Methods and compositions for the treatment of monogenic diseases
EP4321623A3 (en) * 2016-07-15 2024-05-15 Salk Institute for Biological Studies Methods and compositions for genome editing in non-dividing cells
JP2022505139A (ja) 2018-10-15 2022-01-14 フォンダッツィオーネ・テレソン ゲノム編集の方法及び構築物
AU2020256225B9 (en) * 2019-04-03 2025-04-10 Regeneron Pharmaceuticals, Inc. Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
CN113058041B (zh) * 2020-08-27 2022-04-05 华东师范大学 一种用于治疗庞贝氏病的产品
CN112741906B (zh) * 2019-10-31 2022-07-05 华东师范大学 一种用于治疗b型血友病的产品

Similar Documents

Publication Publication Date Title
US12297447B2 (en) Gene therapy for juvenile Batten disease
EP2970943B1 (en) Vectors comprising stuffer/filler polynucleotide sequences and methods of use
JP7832262B2 (ja) 肝特異的ウイルスプロモーター及びその使用方法
AU2014293253B2 (en) Variant AAV and compositions, methods and uses for gene transfer to cells, organs and tissues
JP2022549380A5 (https=)
CN116732069A (zh) 酸性α-葡萄糖苷酶变体及其用途
CA3145112A1 (en) Engineered nucleic acid regulatory element and methods of uses thereof
KR20210096168A (ko) 신경퇴행성 질환을 위한 유전자 요법
EP3236984A1 (en) Adeno-associated virus vectors encoding modified g6pc and uses thereof
WO2023004365A1 (en) Vector constructs for delivery of nucleic acids encoding therapeutic proteasome activator complex subunits and methods of using the same
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
JP2025515030A5 (https=)
CN115605266A (zh) Dysferlin双载体的基因疗法
WO2024050547A2 (en) Compact bidirectional promoters for gene expression
EP4518907A1 (en) Homology independent targeted integration for gene editing
EP4142801A1 (en) Compositions and methods for reducing nuclease expression and off-target activity using a promoter with low transcriptional activity
CN120173939A (zh) 肝脏特异性启动子及其用途
CN120210188A (zh) 用于调控基因表达的杂合启动子及其用途
White et al. Gene therapy introduction and overview